IRA biosimilar measure intended to boost uptake so far has 'limited' impact: report

[cafead]

via It’s been two years since the Inflation Reduction Act (IRA) was passed, and, while the law's Medicare-negotiated price cuts haven’t yet gone into effect, a change surrounding biosimilar reimbursement rates was instated in 2022.

article source